Identification of a Novel Mitochondrial tRNA Mutation in Chinese Family with Type 2 Diabetes Mellitus
DOI: https://doi.org/10.2147/pgpm.s438978
2024-04-18
Pharmacogenomics and Personalized Medicine
Abstract:Xing Li, Jinyao Shang, Shuang Li, Yue Wang Department of Endocrinology, Ordos Center Hospital, Ordos, Inner Mongolian, 017010, People's Republic of China Correspondence: Xing Li, Department of Endocrinology, Ordos Center Hospital, Sudu Street No. 6, Kangbashi District, Ordos, Inner Mongolian, 017010, People's Republic of China, Tel/Fax +86-0477-8167761, Email Background: Mutations in mitochondrial tRNA (mt-tRNA) could be the origin of some type 2 diabetes mellitus (T2DM) cases, but the mechanism remained largely unknown. Aim: The aim of this study was to assess the impact of a novel mitochondrial tRNA Cys /tRNA Tyr A5826G mutation on the development and progression of T2DM. Methods: A four-generation Han Chinese family with maternally inherited diabetes underwent clinical, genetic and biochemical analyses. The mitochondrial DNA (mtDNA) mutations of three matrilineal relatives were screened by PCR-Sanger sequencing. Furthermore, to see whether m.A5826G mutations affected mitochondrial functions, the cybrid cell lines were derived from three subjects with m.A5826G mutation and three controls without this mutation. ATP was evaluated by luminescent cell viability assay, mitochondrial membrane potential (MMP), and reactive oxygen species (ROS) were determined by flow cytometry. The student's two-tailed, unpaired t -test was used to assess the statistical significance between the control and mutant results. Results: The age at onset of diabetes in this pedigree varied from 40 to 63 years, with an average of 54 years. Mutational analysis of mitochondrial genomes revealed the presence of a novel m.A5826G mutation. Interestingly, the m.A5826G mutation occurred at the conjunction between tRNA Cys and tRNA Tyr , a very conserved position that was critical for tRNAs processing and functions. Using trans-mitochondrial cybrid cells, we found that mutant cells carrying the m.A5826G showed approximately 36.5% and 22.4% reductions in ATP and MMP, respectively. By contrast, mitochondrial ROS levels increased approximately 33.3%, as compared with the wild type cells. Conclusion: A novel m.A5826G mutation was identified in a pedigree with T2DM, and this mutation would lead to mitochondrial dysfunction. Thus, the genetic spectrum of mitochondrial diabetes was expanded by including m.A5826G mutation in tRNA Cys /tRNA Tyr , our study provided novel insight into the molecular pathogenesis, early diagnosis, prevention and clinical treatment for mitochondrial diabetes. Keywords: type 2 diabetes, m.A5826G, tRNA Cys /tRNA Tyr , mitochondrial dysfunction Mitochondria are distinct organelles within eukaryotic cells that are involved in oxidative phosphorylation (OXPHOS). They carry their own genetic material, in humans, mitochondrial DNA (mtDNA) is a circular molecule comprising 16,569-bp that is essential for respiratory chain functions. 1 It encodes 13 OXPHOS-related proteins, as well as 22 tRNAs and 2 rRNAs. MtDNA in humans shows a strictly maternal inheritance as during fertilization of the oocyte the paternal mitochondria are not retained within the fertilized oocyte. 2 Mitochondrial diseases are a group of genetic disorders characterized by defects in OXPHOS and caused by mutations in nuclear DNA (nDNA) and mtDNA that encode proteins involved in mitochondrial functions. 3 Mitochondrial diseases are frequently related to the damage of nerves and muscle conducting to deafness and visual loss. Among them, T2DM is one of the most common types of mitochondrial diseases. It is a complex, heritable and heterogeneous condition that manifests in a range of clinical phenotypes, including hyperglycemia, diabetic ketoacidosis, retinopathy, nephropathy, foot problem which remain big challenging for clinicians. 4 However, its pathophysiology is still undetermined. In recent years, it had been found that mutations in mtDNA may lead to T2DM concomitant with symptoms caused by damage to nerves and muscles. 5–8 In particular, the well-known m.A3243G mutation in tRNA Leu(UUR) was implicated in the pathogenesis and progression of T2DM in many families worldwide. 9–11 This mutation affected the structural stability, aminoacylation rate and post-transcriptional modification of tRNA Leu(UUR) . 12 In addition to the m.A3243G mutation, some case–control studies suggested that tRNA Trp A5514G and tRNA Ser(AGY) C12337T, 13 tRNA Glu A14692G, 14 tRNA Ala T5587C and ND5 T12338C 15 mutations were associated with T2DM. In fact, mt-tRNA pathogenic mutations have structural and functional consequences, such as a -Abstract Truncated-
pharmacology & pharmacy